| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |